Parry-Romberg syndrome
Jon Stone P arry-Romberg syndrome, which is also called progressive facial hemiatrophy, overlaps with a condition known as linear scleroderma "en coup de sabre". It is a rare, acquired, neurocutaneous syndrome of unknown aetiology. The principle features are atrophy of the soft tissues, and sometimes the bone, on one half of the face or forehead without facial weakness. Sometimes the atrophy extends to the limbs, usually on the same side, and there may be various ophthalmological and neurological complications. As a neurologist you should know about this syndrome because you will probably encounter at least one or two cases during your career, perhaps to assess new onset facial asymmetry, hemi-masticatory spasm, or because a patient already with the diagnosis has developed epilepsy or difficult migraine. Patients with Parry-Romberg syndrome present to various other clinics-especially dermatology, plastic surgery, and rheumatology. 
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cLiNicAL FEATuRES
The main feature is hemiatrophy of facial tissues, typically fat, but variably skin, other connective tissue, and sometimes bone (fig 1) . The jaw, mouth, cheek, or forehead may all be affected. Patients range in severity from those with barely perceptible asymmetry to severe disfigurement. The range of clinical features is outlined in the table. Where the atrophy meets normal tissue on the other side of the face, it may produce a "line". Around 25% of patients with facial hemiatrophy have a more definite vertical or diagonal "line" on their forehead as a result of cutaneous sclerosis (rather than atrophy of the deeper tissues) (fig 2) . These lines tend to follow "Blaschko's lines" which are the diagonal/ vertical lines on the forehead, of uncertain origin which some skin diseases tend to follow. 1 When a pathological "line" is present it is called scleroderma "en coup de sabre" ("in a sabre cut") and is classified separately in many textbooks as a form of linear scleroderma affecting the head. Scleroderma "en coup de sabre" does, however, appear to be an overlapping condition with Parry-Romberg syndrome and shares a similar list of associated features. 2 The other terms to be familiar with in this area are "morphoea" (which is an umbrella term for sclerodermatous or fibrotic lesions of the skin) and Gower's panatrophy (which is the name for a "ParryRomberg like" lipoatrophy just affecting a limb). Systemic sclerosis is an unlikely association of any of these conditions. 
NEuRoLogicAL AND PSycHiATRic coMPLicATioNS
Migraine and facial pain are the commonest neurological symptoms in this patient group. Occasionally, epilepsy may occur and can sometimes be related directly to a brain abnormality ipsilateral to the skin lesion. This may be visible only on MRI as a lesion in the underlying grey or sometimes white matter. Rarely, the brain imaging abnormalities are contralateral or bilateral (fig 3) . Very few of these cases have come to biopsy but those that have mostly suggest an inflammatory problem. There are a range of other cerebral abnormalities which have been associated with Parry-Romberg syndrome and scleroderma "en coup de sabre" on imaging and neuropathological grounds. These include cerebral hemiatrophy, meningeal thickening, cortical dysgenesis, calcified lesions, aneurysms, and intracranial vascular malformations. There is one reported fatal case in a child with associated "Rasmussentype" encephalitis. From a psychological point of view, the disfigurement is often the worst symptom, particularly since this is an acquired condition.
EPiDEMioLogy
This is not well described. A few years ago I carried out a study of the condition, recruiting 205 patients from a US patient run website called the "Romberg's Connection" (fig 4) . 3, 4 This website brought together many people with Parry-Romberg syndrome who previously had no opportunity to contact anyone else with the same condition. The interpretation of the findings was limited by the methodology but the average age of onset was around 10 years old with about one third starting after the age of 15 and some as late as 40. The disease typically progresses over a few years (but sometimes much longer) and then arrests. It does not spontaneously improve once it is established. There are anecdotal reports of worsening during pregnancy or after childbirth. The prevalence is at least 1/700,000 and it may be more common in females.
HiSToRy
The condition was described by an English physician, Caleb Parry, as early as 1815 and subsequently elaborated in 1846 by Moritz Romberg (he of "Romberg's sign"). In the subsequent 190 years there hasn't been a great deal of progress in understanding or treating the condition-most of the literature consists of just case reports.
AETioLogy
There are no systematic studies to guide us but the "best guess" is that it is an autoimmune mediated condition. The skin pathology if caught at the onset shows inflammatory changes. Supportive evidence for an inflammatory hypothesis includes: a higher frequency of 
iNVESTigATioNS
For a patient who only has facial asymmetry, a clinical diagnosis can be made without investigations. MRI is the brain imaging of choice for patients with neurological symptoms. A lumbar puncture and autoantibodies would be reasonable investigations in a patient who is presenting because of epilepsy.
TREATMENT
There are no published trials of treatment. Most patients do not have severe enough disease to warrant immunosuppression but they may be interested in restorative plastic surgery which includes fat or silicon implants, flap/pedicle grafts, or bone implants. 5 Patients tend to be moderately satisfied with the outcome of these procedures. However, they should be made aware that fat injections may simply be resorbed if the disease is still active. For those with more severe and progressive disease, treatments used include methotrexate (for which there is limited evidence in linear scleroderma), corticosteroids, cyclophosphamide, and azathioprine but it is unclear how beneficial they are.
